Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and...

Related Keywords

United States ,Israel ,Brazil ,Carmiel ,Ha Afon ,American ,Chiesi Farmaceutici ,Myrld Holida ,Chuck Padala ,Protalix Biotherapeutics Inc ,National Organization For Rare Disorders ,University Of Iowa Stead Family Children Hospital ,Drug Administration ,Prnewswire Protalix Biotherapeutics Inc ,Exchange Commission ,Pfizer Inc ,Fabry Disease ,Standard Time ,Iowa Stead Family Children ,Physician Assistant ,Pediatric Bone Marrow Transplant ,Lysosomal Storage Disorder ,Clinical Trial Investigator ,Lysosomal Storage ,National Organization ,Rare Disorders ,Metachromatic Leukodystrophy ,Lysosomal Acid Lipase Deficiency ,Private Securities Litigation Reform Act ,Protalix Biotherapeutics ,Nc ,